Euro vs US Dollar

Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.

Registrieren

OMGA Omega Therapeutics Inc

0,82

0,0236 (2,96%)

28 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form 3 - Initial statement of beneficial ownership of securities

Omega Therapeutics (NASDAQ:OMGA)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more Omega Therapeutics Charts.

Omega Therapeutics (NASDAQ:OMGA)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more Omega Therapeutics Charts.

News Omega Therapeutics Inc

Form 4 - Statement of changes in beneficial ownership of securities
Mittwoch 27 November 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 3 - Initial statement of beneficial ownership of securities
Mittwoch 27 November 2024 (2 Tage vor) • Edgar (US Regulatory)

Form 4 - Statement of changes in beneficial ownership of securities
Samstag 16 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Omega Therapeutics Announces Successful Completion of Phase 1 Trial for Novel Epigenomic Controller, Prioritized Pipeline, Leadership Changes, and Third Quarter 2024 Financial Results
Donnerstag 14 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

Flagship Pioneering Announces Appointment of Junaid Bajwa as Senior Partner, Head of United Kingdom, and Science Partner for Pioneering Intelligence
Mittwoch 23 Oktober 2024 (1 Monat vor) • PR Newswire (US)

Omega Therapeutics to Present Multiple Posters Highlighting Versatile Platform Capabilities at Upcoming Scientific Meetings
Dienstag 15 Oktober 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 4 Oktober 2024 (2 Monate vor) • Edgar (US Regulatory)

Invaio Sciences Appoints André Andonian as Chairman of the Board of Directors
Donnerstag 3 Oktober 2024 (2 Monate vor) • PR Newswire (US)

Omega Therapeutics Announces Publication of Epigenomic Controller OTX-2002 Preclinical Data in Nature Communications
Dienstag 17 September 2024 (2 Monate vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 30 August 2024 (3 Monate vor) • Edgar (US Regulatory)

Omega Therapeutics Announces Jennifer Nelson, Ph.D., as Senior Vice President of Research
Mittwoch 14 August 2024 (4 Monate vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 6 August 2024 (4 Monate vor) • Edgar (US Regulatory)

Weitere Omega Therapeutics Inc News-Artikel

Deutsche Telekom (QX)

Invesco QQQ Trust Series 1

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen